Hai-ge Chen

Renji Hospital

Papers

2

Total Citations

14

H-Index

2

About

Dr. Hai-ge Chen is a leading urologic surgeon and researcher whose work focuses on advancing surgical outcomes for patients with bladder cancer, particularly through robot-assisted techniques. His major contributions center on comparing long-term outcomes of orthotopic neobladder versus ileal conduit urinary diversion following robot-assisted radical cystectomy (RARC). As a key member of the Asian RARC Consortium, Dr. Chen led a landmark multicenter study that provided critical evidence on the optimal urinary diversion method, demonstrating that orthotopic neobladder offers comparable oncologic control with potential quality-of-life benefits. This work, published in 2024, has already garnered 12 citations, reflecting its immediate impact on clinical practice. Dr. Chen’s research addresses a longstanding debate in urologic oncology, offering surgeons and patients clearer guidance on treatment decisions. His collaborative efforts across Asian centers underscore his commitment to generating high-quality, real-world evidence. By systematically evaluating functional and oncologic outcomes, Dr. Chen continues to shape the evolution of minimally invasive bladder cancer surgery, improving recovery and long-term results for patients worldwide.

Research Focus

Key Achievements

2
H-Index
2
Papers
14
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Long-Term Outcomes of Orthotopic Neobladder Versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium
12 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Renji Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago